Ginsenoside derivative Rp1 could modulate transporter-based classical MDR by decreasing MDR-1 activity to inhibit effluxes of anticancer drugs, and synergistically induced cell death with anti-cancer drugs in drug-resistant cell lines 12. This evidence concerns the gene ABCB1 and cancer.